Gene Sequencing

ProPhase Labs Inc (NASDAQ: PRPH) has acquired privately-held Nebula Genomics for approximately $14.6 million in a combination of stock and cash.  Prophase will integrate Nebula's whole genome sequencing services with its clinical diagnostic testing services....

The New York Times on Tuesday discussed the creation of Helix, a new gene sequencing venture. The creation of the new company has the backing and support of Illumina, Inc. (NASDAQ: ILMN), along with the investment firms Warburg Pincus and Sutter Hill Ventures. According to the publication, the...